Drugs and Diagnostics for Hematological Disorders: Global Markets

Mar 2013| PHM116A| BCC Publishing

Report Highlights

The total global market for hematological disorder drugs and diagnostics in 2012 was estimated at nearly $72.9 billion. By 2017, the market is expected to reach $99.1 billion, growing at a compound annual growth rate (CAGR) of 6.4% between 2012 and 2017.

Report Includes

  • An overview of the global market for drugs and diagnostics for hematological disorders.
  • Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics.
  • A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies.
  • Delineation of drugs approved by the FDA for hematological disorders.
  • Comprehensive profiles of key companies in the industry.

SCOPE OF THE STUDY

The scope of this study is testing, screening technology and also therapeutics markets for hematological disorders and blood cancers.  The report also includes the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends and new developments.

ABOUT THE AUTHOR

Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience.  She has managed preclinical discovery programs from target identification, including IND enabling studies, and assisted out-licensing and portfolio development activities.  Her strong focus areas include oncology, dermatology and cardiovascular diseases.  She has extensive experience working with early start-ups to fulfill operational obligations while minimizing overall operational cost and burden.

Frequently Asked Questions (FAQs)

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drugs and Diagnostics for Hematological Disorders: Global Markets429Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW57Free
Chapter- 4: HEMATOLOGICAL CANCERS 11Free
Chapter- 5: HEMATOLOGICAL CANCERS: LEUKEMIA29Free
Chapter- 6: HEMATOLOGICAL CANCERS: LYMPHOMA15Free
Chapter- 7: HEMATOLOGICAL CANCERS: MYELOMA14Free
Chapter- 8: HEMATOLOGICAL CANCER: MYELODYSPLASTIC SYNDROMES 12Free
Chapter- 9: HEMATOLOGICAL CANCERS: MYELOPROLIFERATIVE DISORDERS31Free
Chapter- 10: WORLDWIDE INCIDENCE: BLOOD DISORDERS AND BLOOD CANCER70Free
Chapter- 11: HEMATOLOGY INSTRUMENTS AND REAGENTS: A GLOBAL MARKET PERSPECTIVE28Free
Chapter- 12: BLOOD DISEASES TREATMENTS MARKET53Free
Chapter- 13: HEMATOLOGICAL CANCER THERAPIES: MARKET62Free
Chapter- 14: PATENT LANDSCAPE AND CURRENT DEVELOPMENTS 16Free
Chapter- 15: SELECTED COMPANY PROFILES18Free
Drugs and Diagnostics for Hematological Disorders: Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS